Foto del docente

Fabrizio De Ponti

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: BIO/14 Pharmacology


vai alle Pubblicazioni

Publications prior to 2004

1) Raschi E, De Ponti F. Lubiprostone: pharmacokinetic, pharmacodynamic, safety and regulatory aspects in the treatment of constipation-predominant irritable bowel syndrome. Expert Opin. Drug Metab. Toxicol. 2014;10:293-305. PMID: 24387275

2) Raschi E, Poluzzi E, Godman B, Koci A, Moretti U, Kalaba M, Bennie M, Barbui C, Wettermark B, Sturkenboom M, De Ponti F. Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.

PLoS One 2013;8:e81208. PMID: 24278396

3) Poluzzi E, Piccinni C, Raschi E, Rampa A, Recanatini M, De Ponti F. Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective. Curr. Med. Chem. 2014;21:417-36. PMID: 24164197

4) Dothel G, Vasina V, Barbara G, De Ponti F. Animal models of chemically induced intestinal inflammation: predictivity and ethical issues. Pharmacol. Ther.;139:71-86. PMID: 23563278

5) Poluzzi E, Raschi E, Koci A, Moretti U, Spina E, Behr ER, Sturkenboom M, De Ponti F. Antipsychotics and torsadogenicrisk: signals emerging from the US FDA Adverse Event Reporting System database. Drug Saf. 2013;36:467-79. PMID: 23553446

6) De Ponti F. Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front. Pharmacol. 2013;4:7. doi: 10.3389/fphar.2013.00007. PMID: 23378837